1
|
Zhu F, Wolters FJ, Yaqub A, Boersma H, Ikram MA, Kavousi M. Plasma amyloid-beta in relation to cardiac function and risk of heart failure in the general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Amyloid-β is a major hallmark of Alzheimer's disease, and its pathology has been hypothesized as a multiple organ syndrome that may also affect cardiac function. There are limited data on association of plasma amyloid-β with cardiac dysfunction and risk of HF in the general population.
Objective
To determine the association of plasma amyloid-β40 (Aβ40) and amyloid-β42 (Aβ42) with echocardiographic measurements of cardiac dysfunction, and with incident heart failure (HF) in the general population.
Methods
We included 4156 participants of the population-based cohort (mean age 71.4 years, 57.1% women), who had plasma amyloid-β measured between 2002 and 2005, and were free of dementia and HF at baseline. Multivariable linear regression models were used to explore the associations of plasma Aβ40 and Aβ42 with echocardiographic measures. Participants were followed for the occurrence of HF until December 2016. Cause-specific hazard models were used to assess the association of plasma amyloid-β with incident HF and competing risk event. Models were adjusted for cardiovascular risk factors.
Results
Higher plasma Aβ40 concentrations were associated with lower left ventricular ejection fraction (β, −0.39; 95% CI, −0.68 to −0.10) and larger left ventricular mass (β, 0.70; 95% CI, 0.06 to 1.34). Aβ42 was not significantly associated with echocardiographic measures cross-sectionally. During follow-up (median 10.2 years), 472 incident HF cases were identified. Higher plasma Aβ40 was associated with an increased risk of incident HF (HR, 1.32; 95% CI, 1.15 to 1.51), more profound in men than in women (P value for interaction: 0.022). One SD increase in Aβ40 was associated with a 31% increase in the hazard of HF in men (HR, 1.32; 95% CI, 1.14 to 1.54) but the association was not significant in women (HR, 1.06; 95% CI, 0.93 to 1.20). Higher plasma Aβ42 concentrations were associated with increased risk of HF (HR, 1.12; 95% CI, 1.02 to 1.24), while further adjustment for concomitant Aβ40 attenuated this association (HR, 1.03; 95% CI, 0.92 to 1.16).
Conclusion
Higher levels of plasma Aβ40 were independently associated with worse cardiac function and higher risk of new-onset HF in the general population, in particular among men.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): The Netherlands Organization for Health Research and Development (ZonMw); the Dutch Heart Foundation;This study is further funded by the European Union's Horizon 2020 research and innovation programme as part of the Common mechanisms and pathways in Stroke and Alzheimer's disease (CoSTREAM) project.
Collapse
Affiliation(s)
- F Zhu
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - F J Wolters
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - A Yaqub
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - H Boersma
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - M A Ikram
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - M Kavousi
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| |
Collapse
|
2
|
Zhu F, Kaiser Y, Boersma H, Bos D, Kavousi M. Aortic valve calcium in relation to subclinical cardiac dysfunction and risk of heart failure in the general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Emerging evidence suggests that aortic valve calcium (AVC) is associated with adverse cardiovascular outcomes, while the association of (early) AVC with subclinical cardiac dysfunction and with risk of heart failure (HF) remains unclear.
Purpose
To determine the association of CT-assessed AVC with echocardiographic measurements of cardiac dysfunction, and with HF in the general population.
Methods
We included 2,348 participants (mean age 68.5 years, 52% women) of the Rotterdam Study, who had AVC measured between 2003 and 2006, and without a history of HF at baseline. Linear regression models were used to explore cross-sectional associations of AVC with echocardiographic measures at baseline. All participants were followed for HF event until December 2016. Cox proportional hazard models were used to assess the association of AVC with incident HF. Models were adjusted for potential confounders.
Results
The presence of AVC was associated with 3.14 g/m2 (95% CI, 1.50 to 4.79) higher mean left ventricular mass indexed by body surface area. One-unit larger log (AVC+1) was associated with 0.01 mm (95% CI 0.01 to 0.02) larger mean left atrial size. During a median follow-up of 9.8 years, 182 incident HF cases were identified. Presence of AVC was associated with 37% greater risk for HF (HR, 1.37; 95% CI, 1.01 to 1.87). One-unit larger log (AVC+1) was associated with 11% larger risk of HF (HR, 1.11; 95% CI, 1.04 to 1.18). Compared with the AVC =0, AVC ≥100 had 1.70 folded risk of HF (HR, 1.70; 95% CI, 1.17 to 2.49).
Conclusions
The levels of AVC were associated with markers of left ventricular structure and with risk of HF, independent of traditional cardiovascular risk factors. Larger CT-assessed AVC is an indicative of increased risk for development of HF.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Netherlands Organization for the Health Research and Development (ZonMw)Dutch Heart Foundation (03-004-2021-T050)
Collapse
Affiliation(s)
- F Zhu
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - Y Kaiser
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - H Boersma
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - D Bos
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| | - M Kavousi
- Erasmus University Medical Centre , Rotterdam , The Netherlands
| |
Collapse
|
3
|
Ter Hoeve N, Den Uijl I, Sunamura M, Stam HJ, Boersma H, Lenzen MJ, Brouwers RWM, Tenbult-Van Limpt NCCW, Kemps HMC, Van Den Berg-Emons HJG. Tailor-made cardiac rehabilitation for patients with obesity: results of the OPTICARE-XL randomized controlled trial. Eur J Prev Cardiol 2022. [DOI: 10.1093/eurjpc/zwac056.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Dutch Organisation for Health Research and Development (ZonMW) and Capri Cardiac Rehabilitation
Background
More than a third of the patients referred to cardiac rehabilitation (CR) suffers from obesity, and this number is growing. However, in patients with obesity, standard CR is not effective in achieving the recommended physical activity levels and results achieved in weight loss and health related quality of life (HRQOL) are unsatisfactory.
Purpose
To describe the effectiveness of a new state of the art CR program designed for patients with obesity, OPTICARE XL, on weight, physical activity and HRQOL.
Methods
A total of 201 patients that were referred to CR after a diagnosis of coronary artery disease (CAD) or atrial fibrillation (AF) and a BMI≥30 were randomized to standard CR (n=99) or OPTICARE XL CR (n=102). Standard CR consists of a 6 till 12 week aerobic exercise program, supplemented with cardiovascular lifestyle education. OPTICARE XL CR is a one-year intervention including aerobic and strength exercise, behavioral coaching on diet and physical activity and an after-care program. Weight was measured with a calibrated weight scale, physical activity (steps/day) was measured with an Actigraph GT3X+, and HRQOL with the MacNew questionnaire. Data was analyzed by means of linear mixed-effect models.
Results
Included patients had a mean age of 59 years, were predominantly male (73%) and the majority was referred to CR after a CAD (66% CAD, 34% AF). Patients in the OPTICARE XL group showed on average greater weight loss three months after the start of CR (mean change -3.6 kg vs -1.8 kg, respectively, p=0.002). Six months post CR, changes in body weight were equal between groups (-2.5 kg in both groups, p=0.959). No significant between-group differences were seen in improvements in physical activity both three months after the start of CR (+880 steps/day for OPTICARE XL vs +481 steps/day for standard CR, p=0.169) and six months post CR (+331 steps/ day vs +283 steps/day, p=0.919). With regard to HRQOL score, also no significant between groups differences in improvements were seen both three months after the start of CR (+0.6 for OPTICARE XL vs +0.5 for standard CR, p=0.169) and six months post CR (+0.5 for both groups, p=0.907).
Conclusion
OPTICARE XL had added value on the short-term, but this did not sustain on the long-term. We suggest to re-evaluate the OPTICARE XL program to expand short-term effects.
Collapse
Affiliation(s)
- N Ter Hoeve
- Capri Cardiac Rehabilitation, Rotterdam, Netherlands (The)
| | - I Den Uijl
- Erasmus University Medical Centre, Department of Rehabilitation Medicine, Rotterdam, Netherlands (The)
| | - M Sunamura
- Capri Cardiac Rehabilitation, Rotterdam, Netherlands (The)
| | - HJ Stam
- Erasmus University Medical Centre, Department of Rehabilitation Medicine, Rotterdam, Netherlands (The)
| | - H Boersma
- Erasmus University Medical Centre, Cardiology, Thoraxcenter, Rotterdam, Netherlands (The)
| | - MJ Lenzen
- Erasmus University Medical Centre, Cardiology, Thoraxcenter, Rotterdam, Netherlands (The)
| | - RWM Brouwers
- Maxima Medical Centre, Eindhoven, Netherlands (The)
| | | | - HMC Kemps
- Maxima Medical Centre, Eindhoven, Netherlands (The)
| | - HJG Van Den Berg-Emons
- Erasmus University Medical Centre, Department of Rehabilitation Medicine, Rotterdam, Netherlands (The)
| |
Collapse
|
4
|
Boersma H, Peters M, Cahn W, Verhoeff J. PO-1504 The effect of psychiatric comorbidities on treatment decisions for - and survival after radiotherapy. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07955-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Ramlakhan K, Tobler D, Greutmann M, Schwerzmann M, Baris L, Yetman A, Nihoyannopoulos P, Manga P, Boersma H, Johnson M, Hall R, Roos-Hesselink J. Aortic coarctation in pregnancy: outcomes and predictors for cardiovascular and hypertensive complications. Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Pregnancy in women with repaired aortic coarctation (CoA) has a moderately increased risk (mWHO II-III) of an adverse cardiovascular, obstetric or fetal event, but prospective data to validate this estimated risk is scarce.
Purpose
We examined maternal and fetal outcomes in pregnant women with unrepaired and repaired CoA to identify predictors of adverse outcomes.
Methods
Pregnancies in women with CoA were selected from the worldwide prospective Registry of Pregnancy and Cardiac Disease (ROPAC, n=5739). The frequency and predictors of major adverse cardiac events (MACE, defined as maternal cardiac death, heart failure, atrial fibrillation/flutter, ventricular tachyarrhythmia, endocarditis, thromboembolic events, aortic dissection and acute coronary syndrome), and hypertensive complications (defined as pregnancy-induced hypertension, (pre)eclampsia or HELLP syndrome) were analyzed.
Results
Of 303 pregnancies in women with CoA (median age 30 years, median pregnancy duration 39 weeks), 10% were in women with unrepaired CoA and 27% in women with pre-existing hypertension. There were no maternal deaths. There were 4 neonatal deaths of which 3 occurred after a spontaneous extreme preterm birth. MACE occurred in 4.3% of pregnancies, predominantly involving heart failure (3.3%). MACE rate was similar in unrepaired vs repaired CoA (3.4% vs 4.4%, p=0.814). Predictors of MACE included pre-pregnancy clinical signs of heart failure (OR 31.8, 95% CI 6.8–147.7), LVEF <40% (OR 10.4, 95% CI 1.8–59.5), NYHA class >1 (OR 11.4, 95% CI 3.6–36.3), cardiac medication use (OR 4.9, 95% CI 1.3–18.3) and living in an emerging country (OR 4.88, 95% CI 1.58–15.07). Hypertensive complications occurred in 6.3%, more often in the subgroup with pre-existing hypertension (11% vs 5%, p=0.040). Pre-existing hypertension was the only predictor (OR 2.6, 95% CI 1.01–6.6). Caesarean section was performed in 50% of the total cohort.
Conclusions
Pregnancies in women with CoA are safe, well tolerated and MACE and hypertensive complication rates are low. These findings support mWHO risk score reevaluation to mWHO II for women with CoA without cardiac impairment.
Funding Acknowledgement
Type of funding source: Foundation. Main funding source(s): ESC EURObservational Research Programme (EORP)
Collapse
Affiliation(s)
- K.P Ramlakhan
- Erasmus University Medical Centre, Department of Cardiology, Rotterdam, Netherlands (The)
| | - D Tobler
- University Hospital Basel, Department of Cardiology, Basel, Switzerland
| | - M Greutmann
- University Heart Center, Department of Cardiology, Zurich, Switzerland
| | - M Schwerzmann
- Kantonsspital, Department of Cardiology, St Gallen, Switzerland
| | - L Baris
- Erasmus University Medical Centre, Department of Cardiology, Rotterdam, Netherlands (The)
| | - A.J Yetman
- Children's Hospital and Medical Center, Division of Pediatric Cardiology, Omaha, United States of America
| | - P Nihoyannopoulos
- National Heart and Lung Institute, Department of Cardiology, London, United Kingdom
| | - P Manga
- University of the Witwatersrand, Division of Cardiology, Department of Internal Medicine, Johannesburg, South Africa
| | - H Boersma
- Erasmus University Medical Centre, Department of Clinical Epidemiology, Rotterdam, Netherlands (The)
| | - M.R Johnson
- Imperial College London, Department of Obstetric Medicine, London, United Kingdom
| | - R Hall
- University of East Anglia, Department of Cardiology, Norwich, United Kingdom
| | - J.W Roos-Hesselink
- Erasmus University Medical Centre, Department of Cardiology, Rotterdam, Netherlands (The)
| |
Collapse
|
6
|
Bouwens E, Schuurman A, Akkerhuis K, Baart S, Caliskan K, Brugts J, Van Ramshorst J, Germans T, Umans V, Boersma H, Kardys I. Serially measured cytokines and cytokine receptors in relation to clinical outcome in patients with stable heart failure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Activation of the inflammatory response in heart failure (HF) may initially serve as a compensatory mechanism. However, on the longer term, this physiological phenomenon can become disadvantageous. Temporal patterns of inflammatory proteins other than CRP have not yet been investigated in patients with stable HF.
Purpose
We aimed to evaluate the association of 17 serially measured cytokines and cytokine receptors with clinical outcome in patients with stable heart failure.
Methods
In 263 patients, 1984 serial, tri-monthly blood samples were collected during a median follow-up of 2.2 (IQR: 1.4–2.5) years. The primary endpoint (PE) composed of cardiovascular mortality, HF-hospitalization, heart transplantation, and LVAD. We selected baseline blood samples in all patients, as well as the two samples closest to the primary endpoint, and the last sample available in event-free patients. Thus, in 567 samples we measured 17 cytokines and cytokine receptors using the Olink Proteomics Cardiovascular III multiplex assay. Associations between biomarkers and PE were investigated by joint modelling.
Results
Median age was 68 (IQR: 59–76) years, with 72% men, 74% NYHA class I-II and a median ejection fraction of 30% (23–38%). 70 patients reached a PE. After adjustment for clinical characteristics (age, sex, diabetes, atrial fibrillation, NYHA class at baseline, diuretics and systolic blood pressure), 7 biomarkers were associated with the PE (Figure). Interleukin-1 receptor type 1 (IL1RT1) showed the strongest association: HR 2.65 [95% CI: 1.78–4.21]) per standard deviation change in level (NPX) at any point in time during follow-up, followed by Tumor necrosis factor receptor 1 (TNF-R1): 2.25 [1.66–3.08], and C-X-C motif chemokine 16 (CXCL16): 2.18 [1.59–3.04]. After adjustment for baseline N-terminal pro–B-type natriuretic peptide, high-sensitive troponin T and C-reactive protein however, only IL1RT1 and TNF-R1 remained significantly associated with the PE.
Conclusion
Repeatedly measured levels of several cytokines and cytokine receptors are independently associated with clinical outcome in stable HF patients. These results suggest that repeated measurements of these biomarkers, in addition to established cardiac biomarkers, may contribute to personalized risk assessment and herewith better identify high-risk patients.
Figure 1. Associations between levels of cytokines and cytokine receptors and the primary endpoint.
Funding Acknowledgement
Type of funding source: Other. Main funding source(s): This work was supported by the Jaap Schouten Foundation and the Noordwest Academie.
Collapse
Affiliation(s)
- E Bouwens
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - A Schuurman
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - K.M Akkerhuis
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - S.J Baart
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - K Caliskan
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - J.J Brugts
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | | | - T Germans
- Northwest Clinics, Cardiology, Alkmaar, Netherlands (The)
| | - V.A.W.M Umans
- Northwest Clinics, Cardiology, Alkmaar, Netherlands (The)
| | - H Boersma
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - I Kardys
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| |
Collapse
|
7
|
Bouwens E, Van Den Berg VJ, Akkerhuis KM, Baart S, Caliskan K, Brugts JJ, Mouthaan H, Van Ramshorst J, Germans T, Umans VA, Boersma H, Kardys I. 5948Circulating biomarkers of cell adhesion in relation to clinical outcomes in patients with chronic heart failure: the Bio-SHiFT study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiovascular inflammation and vascular endothelial dysfunction are present in chronic heart failure (CHF), and cellular adhesion molecules are considered to play a key role in these mechanisms. The temporal patterns of the blood biomarkers involved could provide further insights into these processes.
Purpose
We aimed to evaluate the prognostic value of the temporal patterns of blood biomarkers of cell adhesion in stable patients with CHF.
Methods
In 263 patients, a median of 9 (IQR: 5–10) serial, tri-monthly blood samples were collected during a median follow-up of 2.2 (IQR: 1.4–2.5) years. The composite primary endpoint (PE) of cardiovascular mortality, HF-hospitalization, heart transplantation and LVAD was reached in 70 patients. For efficiency, we selected all baseline samples, the two samples closest to a PE, and the last sample available for event-free patients. Thus, in 567 samples we measured twelve biomarkers of cell adhesion using the Olink Proteomics Cardiovascular III multiplex assay. Associations between biomarkers and first PE were investigated by combining linear mixed effect models and Cox regression (so-called joint model).
Results
Median age was 68 (IQR: 59–76) years, with 72% men and 74% NYHA class I-II. Levels of CD93 (Complement component C1q receptor), CDH5 (VE cadherin), CHI3L1 (Chitinase-3-like protein 1), EPHB4 (Ephrin type-B receptor 4) and JAM-A (Junctional adhesion molecule A) differed at baseline already. The average biomarker evolutions of these markers, and additionally of ICAM-2 (Intercellular adhesion molecule-2), showed different patterns in patients approaching the PE versus those who remained event-free (Figure 1). Repeatedly measured levels of these biomarkers were independently associated with the PE. Corresponding HRs [95% CI] per 1SD increase in log2 level (arbitrary unit) were: CD93: 1.85 [1.29–2.70], CDH5: 1.72 [1.23–2.44], CHI3L1: 2.45 [1.73–3.56], EPHB4: 1.83 [1.33–2.55], ICAM2: 1.74 [1.24–2.46] and JAM-A: 2.07 [1.39–3.18], adjusted for clinical characteristics (age, sex, diabetes, atrial fibrillation, baseline NYHA class, diuretics, systolic blood pressure and eGFR).
Figure 1. Average temporal patterns of cell adhesion biomarkers during follow-up.
Conclusion
CD93, CDH5, CHI3L1, EPHB4, ICAM2 and JAM-A show different patterns as adverse events approach in CHF patients, and their temporal patterns strongly predict clinical outcome. These findings demonstrate the incremental value of repeated measurements of biomarkers of cell adhesion in stable patients with CHF.
Acknowledgement/Funding
This work was supported by the Jaap Schouten Foundation and the Noordwest Academie.
Collapse
Affiliation(s)
- E Bouwens
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - V J Van Den Berg
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - K M Akkerhuis
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - S Baart
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - K Caliskan
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - J J Brugts
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | | | - J Van Ramshorst
- Medical Center Alkmaar, Cardiology, Alkmaar, Netherlands (The)
| | - T Germans
- Medical Center Alkmaar, Cardiology, Alkmaar, Netherlands (The)
| | - V A Umans
- Medical Center Alkmaar, Cardiology, Alkmaar, Netherlands (The)
| | - H Boersma
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - I Kardys
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| |
Collapse
|
8
|
De Bakker M, Van Koeverden ID, Timmerman N, De Kleijn DPV, De Borst GJ, Pasterkamp G, Boersma H, Den Ruijter HM. 4077Sex-specific aging effects on iliofemoral and carotid atherosclerotic plaque composition in vascular surgery patients. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Knowledge on factors that influence atherosclerotic plaque composition may allow improved risk stratification and treatment selection in iliofemoral and carotid atherosclerotic disease, since outcomes of different treatment strategies are influenced by the type of underlying lesions. The sex- and age-related differences in iliofemoral atherosclerotic plaque composition is largely unknown. Unravelling the intertwined relation between sex, age and plaque composition might provide important implications for the treatment of peripheral artery disease.
Purpose
We aimed to elucidate the associations between sex, age and plaque composition in a histopathological analysis of plaque specimens of patients undergoing iliofemoral endarterectomy. Given the systemic nature of atherosclerosis, analyses are replicated in atherosclerotic plaque specimens obtained from patients undergoing carotid surgery.
Methods
Peripheral atherosclerotic plaques of 790 patients who underwent iliofemoral endarterectomy were harvested between 2002 and 2014. A cohort of patients (n=2006) who underwent carotid endarterectomy was used to replicate analyses on sex-specific aging effects in plaques from a different vascular bed. The atherosclerotic plaques were semi-quantitatively analyzed for the presence of lipid cores, plaque calcifications, plaque hemorrhages and collagen, macrophage and smooth muscle cell content, and quantitatively for microvessel density. Patients were stratified by age tertiles and by sex.
Results
Men had a higher prevalence of lipid cores (25.7% versus 20.5%, odds ratio [OR] 1.62 and 95% confidence interval [CI] 1.06–2.45, P=0.025) and plaque hemorrhage (54.3% versus 42.9%, OR 1.62 and 95% CI 1.16–2.54, P=0.004) when compared to women. Women showed an increase in plaque calcifications, plaque hemorrhage and a decrease in macrophages with increasing age (figure panel B, D, E), whereas men only showed a decrease in collagen content (figure panel C). These sex-specific aging effects were replicated in plaques obtained from the carotid arteries.
s
Conclusion
Atherosclerotic iliofemoral plaques derived from men display more rupture-prone characteristics compared to women. However, advanced age was more often associated with an increase in the presence of vulnerable plaque characteristics in women as compared to men in both the iliofemoral and carotid atherosclerotic plaque.
Collapse
Affiliation(s)
- M De Bakker
- Erasmus Medical Center, Department of Cardiology, Rotterdam, Netherlands (The)
| | - I D Van Koeverden
- University Medical Center Utrecht, Laboratory of Experimental Cardiology, Utrecht, Netherlands (The)
| | - N Timmerman
- University Medical Center Utrecht, Department of Vascular Surgery, Utrecht, Netherlands (The)
| | - D P V De Kleijn
- University Medical Center Utrecht, Department of Experimental Vascular Surgery, Utrecht, Netherlands (The)
| | - G J De Borst
- University Medical Center Utrecht, Department of Vascular Surgery, Utrecht, Netherlands (The)
| | - G Pasterkamp
- University Medical Center Utrecht, Laboratory of Clinical Chemistry and Hematology, Utrecht, Netherlands (The)
| | - H Boersma
- Erasmus Medical Center, Department of Cardiology, Rotterdam, Netherlands (The)
| | - H M Den Ruijter
- University Medical Center Utrecht, Laboratory of Experimental Cardiology, Utrecht, Netherlands (The)
| |
Collapse
|
9
|
Stegehuis VE, Wijntjens GWM, Bax M, Meuwissen M, Chamuleau SAJ, Voskuil M, Di Mario C, Vrints C, Haude M, Boersma H, Serruys PW, Piek JJ, Van De Hoef TP. P5620Clinical and hemodynamic determinants of coronary flow reserve in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0564] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Aim
Coronary Flow Reserve (CFR) is a valuable physiological index for the assessment of myocardial flow impairment due to focal or microcirculatory coronary artery disease (CAD). Coronary flow capacity (CFC) is another flow-based concept in diagnosing ischemic heart disease (IHD), based on hyperemic average peak velocity (hAPV) and CFR. We evaluated clinical and hemodynamic factors which potentially influence CFR and CFC in non-obstructed coronary arteries.
Methods
We analysed CFR and CFC of 396 non-obstructed vessels of patients from two large multi-center trials (DEBATE and ILIAS) with stable CAD who were scheduled for percutaneous coronary intervention (PCI). Doppler flow measurements were performed after inducing hyperemia with either intracoronary or intravenous infusion of adenosine.
Results
Akaike's Information Criterion (AIC) revealed the parameters age, female gender, a history of myocardial infarction, hypercholesterolemia, current or previous smoking and rate pressure product (RPP) as independent predictors in the best model of fit for CFR in an angiographically non-obstructed vessel. After multivariate regression analysis age, female gender and RPP remained as determinants of CFR in angiographically non-obstructed vessels. Subsequently, ordered logistic regression analysis revealed that age is associated with a worse CFC.
Conclusion
Clinical and hemodynamic parameters are associated with CFR and to a lesser extent CFC in an angiographically non-obstructed coronary artery. CFC is less sensitive to variations in clinical and hemodynamic parameters than CFR and therefore a promising tool in contemporary clinical decision making in the cardiac catheterization laboratory.
Acknowledgement/Funding
DEBATE: Cardiometrics INC. ILIAS: Dutch Health Insurance Board; RADI Medical Systems, Uppsala, Sweden; and Endosonics, Rancho Cordova, CA.
Collapse
Affiliation(s)
- V E Stegehuis
- Academic Medical Center of Amsterdam, Heart Center, Amsterdam, Netherlands (The)
| | - G W M Wijntjens
- Academic Medical Center of Amsterdam, Heart Center, Amsterdam, Netherlands (The)
| | - M Bax
- Hagaziekenhuis, Cardiology, Den Haag, Netherlands (The)
| | - M Meuwissen
- Amphia Hospital, Cardiology, Breda, Netherlands (The)
| | - S A J Chamuleau
- University Medical Center Utrecht, Cardiology, Utrecht, Netherlands (The)
| | - M Voskuil
- University Medical Center Utrecht, Cardiology, Utrecht, Netherlands (The)
| | - C Di Mario
- Careggi University Hospital (AOUC), Cardiology, Florence, Italy
| | - C Vrints
- University of Antwerp, Cardiology, Antwerp, Belgium
| | - M Haude
- Lukas Hospital GmbH, Cardiology, Neuss, Germany
| | - H Boersma
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - P W Serruys
- Imperial College London, Cardiology, London, United Kingdom
| | - J J Piek
- Academic Medical Center of Amsterdam, Heart Center, Amsterdam, Netherlands (The)
| | - T P Van De Hoef
- Academic Medical Center of Amsterdam, Heart Center, Amsterdam, Netherlands (The)
| |
Collapse
|
10
|
Schuurman AS, Tomer A, Akkerhuis KM, Brugts JJ, Constantinescu AA, Van Ramshorst J, Umans VA, Boersma H, Rizopoulos D, Kardys I. P1644Personalized screening intervals for measurement of n-terminal pro-b-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Predefined screening intervals and target levels do not account for variations in temporal patterns of biomarkers between individuals, which may hamper their potential use for therapy guidance. Conversely, a personalized screening approach with screening intervals and target levels based on the evolution of biomarkers in individual patients may further improve risk assessment and therapy guidance.
Purpose
We hypothesize that personalized screening intervals for N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurements in patients with chronic heart failure (CHF) maximize information gain on the individual patient's disease progression, while minimizing the number of necessary measurements. We aim to compare such personalized scheduling of NT-proBNP measurements to a predefined fixed scheduling approach.
Methods
In 263 CHF patients from the Bio-SHiFT study, NT-proBNP was measured trimonthly according to a prespecified, fixed schedule [median: 9 (IQR: 5–10) measurements per patient].The primary composite endpoint (PE) comprised cardiac death, cardiac transplantation, left ventricular assist device implantation or heart failure hospitalization, and occurred in 70 patients (26.6%). Using joint models for time-to-event and longitudinal data, we modelled the association between repeated NT-proBNP measurements and the PE. Using the fitted joint model, for each patient at each follow-up visit, we determined the optimal time point of the next NT-proBNP measurement based on the patient's individual risk profile and the maximum information gain on the patient's prognosis as assessed by the Kullback-Leibler divergence. Personalized scheduling was compared to fixed (trimonthly) scheduling by means of a realistic simulation study, based on a replica of the study population included in the Bio-SHiFT study. In this simulation study, we stopped monitoring NT-proBNP to potentially enable appropriate timely intervention if the cumulative risk of PE exceeded an arbitrary risk threshold of 7.5% within 3-months. We compared personalized scheduling with fixed scheduling in terms of capability of identification of high-risk intervals (whether timely intervention was enabled before occurrence of PE), number of measurements needed, and costs.
Results
Compared to fixed scheduling, personalized scheduling saved on average 2 measurements [personalized; median: 7 (IQR: 7–8) vs. fixed; 9 (IQR: 8–10) measurements], while the start of the time-window identified for therapeutic intervention to avoid the occurrence of PE was similar in both approaches [personalized; median: 6.6 (IQR: 4.5–11.3) vs. fixed; 6.3 (IQR: 4.2–10.3) months before occurrence of PE]. Costs saved were €165 per patient per year.
Figure 1
Conclusion
Personalized scheduling of NT-proBNP measurements in CHF patients shows similar prognostic performance as fixed scheduling, but requires fewer NT-proBNP measurements. This may improve efficiency of natriuretic guided therapy, if the latter were to be installed.
Acknowledgement/Funding
Funding for this study was provided by the Jaap Schouten Foundation and Erasmus MC Efficiency Research grant
Collapse
Affiliation(s)
- A.-S Schuurman
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - A Tomer
- Erasmus Medical Center, Biostatistics, Rotterdam, Netherlands (The)
| | - K M Akkerhuis
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - J J Brugts
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | | | | | - V A Umans
- Northwest Clinics, Cardiology, Alkmaar, Netherlands (The)
| | - H Boersma
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| | - D Rizopoulos
- Erasmus Medical Center, Biostatistics, Rotterdam, Netherlands (The)
| | - I Kardys
- Erasmus Medical Center, Cardiology, Rotterdam, Netherlands (The)
| |
Collapse
|
11
|
Schreuder MM, Boersma H, Roeters Van Lennep JE. P1874Sex-specific analysis on efficacy and safety of statins: a systematic review and quantitative meta-analysis. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - H Boersma
- Erasmus Medical Center, Rotterdam, Netherlands
| | | |
Collapse
|
12
|
van Lier F, Wesdorp F, Liem V, Potters J, Grüne F, Boersma H, Stolker R, Hoeks S. Association between postoperative mean arterial blood pressure and myocardial injury after noncardiac surgery. Br J Anaesth 2018; 120:77-83. [DOI: 10.1016/j.bja.2017.11.002] [Citation(s) in RCA: 126] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Revised: 08/10/2017] [Accepted: 09/12/2017] [Indexed: 11/25/2022] Open
|
13
|
Vroegindewey M, Schuurman A, Kardys I, Anroedh S, Oemrawsingh R, Ligthart J, Garcia-Garcia H, Van Geuns R, Regar E, Van Mieghem N, Serruys P, Boersma H, Akkerhuis K. P2362SYNTAX score is positively correlated with intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with stable coronary artery disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Dedic A, Lubbers M, Schaap J, Lamfers E, Boersma H, Nieman K. P539Coronary CT angiography in women and men suspected of acute coronary syndrome in the era of hs-troponins. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Abstract
Lateral radiographs of the heads of persons between the ages of 58 and 91 years were compared. Few statistically significant differences were found. Almost all linear dimensions in the women were smaller than those in the men.
Collapse
Affiliation(s)
- H. Boersma
- Department of Orthodontics, School of Dentistry, University of Nijmegen, Nijmegen, The Netherlands
| |
Collapse
|
16
|
Taniguchi Y, Takahashi Y, Toba T, Yamada S, Yokoi K, Kobayashi S, Okajima S, Shimane A, Kawai H, Yasaka Y, Smanio P, Oliveira MA, Machado L, Cestari P, Medeiros E, Fukuzawa S, Okino S, Ikeda A, Maekawa J, Ichikawa S, Kuroiwa N, Yamanaka K, Igarashi A, Inagaki M, Patel K, Mahan M, Ananthasubramaniam K, Mouden M, Yokota S, Ottervanger J, Knollema S, Timmer J, Jager P, Padron K, Peix A, Cabrera L, Pena Bofill V, Valera D, Rodriguez Nande L, Carrillo Hernandez R, Mena Esnard E, Fernandez Columbie Y, Bertella E, Baggiano A, Mushtaq S, Segurini C, Loguercio M, Conte E, Beltrama V, Petulla' M, Andreini D, Pontone G, Guzic Salobir B, Dolenc Novak M, Jug B, Kacjan B, Novak Z, Vrtovec M, Mushtaq S, Pontone G, Bertella E, Conte E, Segurini C, Volpato V, Baggiano A, Formenti A, Pepi M, Andreini D, Ajanovic R, Husic-Selimovic A, Zujovic-Ajanovic A, Mlynarski R, Mlynarska A, Golba K, Sosnowski M, Ameta D, Goyal M, Kumar D, Chandra S, Sethi R, Puri A, Dwivedi SK, Narain VS, Saran RK, Nekolla S, Rischpler C, Nicolosi S, Langwieser N, Dirschinger R, Laugwitz K, Schwaiger M, Goral JL, Napoli J, Forcada P, Zucchiatti N, Damico A, Damico A, Olivieri D, Lavorato M, Dubesarsky E, Montana O, Salgado C, Jimenez-Heffernan A, Ramos-Font C, Lopez-Martin J, Sanchez De Mora E, Lopez-Aguilar R, Manovel A, Martinez A, Rivera F, Soriano E, Maroz-Vadalazhskaya N, Trisvetova E, Vrublevskaya O, Abazid R, Kattea M, Saqqah H, Sayed S, Smettei O, Winther S, Svensson M, Birn H, Jorgensen H, Botker H, Ivarsen P, Bottcher M, Maaniitty T, Stenstrom I, Saraste A, Pikkarainen E, Uusitalo V, Ukkonen H, Kajander S, Bax J, Knuuti J, Choi T, Park H, Lee C, Lee J, Seo Y, Cho Y, Hwang E, Cho D, Sanchez Enrique C, Ferrera C, Olmos C, Jimenez - Ballve A, Perez - Castejon MJ, Fernandez C, Vivas D, Vilacosta I, Nagamachi S, Onizuka H, Nishii R, Mizutani Y, Kitamura K, Lo Presti M, Polizzi V, Pino P, Luzi G, Bellavia D, Fiorilli R, Madeo A, Malouf J, Buffa V, Musumeci F, Rosales S, Puente A, Zafrir N, Shochat T, Mats A, Solodky A, Kornowski R, Lorber A, Boemio A, Pellegrino T, Paolillo S, Piscopo V, Carotenuto R, Russo B, Pellegrino S, De Matteis G, Perrone-Filardi P, Cuocolo A, Piscopo V, Pellegrino T, Boemio A, Carotenuto R, Russo B, Pellegrino S, De Matteis G, Petretta M, Cuocolo A, Amirov N, Ibatullin M, Sadykov A A, Saifullina G, Ruano R, Diego Dominguez M, Rodriguez Gabella T, Diego Nieto A, Diaz Gonzalez L, Garcia-Talavera J, Sanchez Fernandez P, Leen A, Al Younis I, Zandbergen-Harlaar S, Verberne H, Gimelli A, Veltman C, Wolterbeek R, Bax J, Scholte A, Mooney D, Rosenblatt J, Dunn T, Vasaiwala S, Okuda K, Nakajima K, Nystrom K, Edenbrandt L, Matsuo S, Wakabayashi H, Hashimoto M, Kinuya S, Iric-Cupic V, Milanov S, Davidovic G, Zdravkovic V, Ashikaga K, Yoneyama K, Akashi Y, Shugushev Z, Maximkin D, Chepurnoy A, Volkova O, Baranovich V, Faibushevich A, El Tahlawi M, Elmurr A, Alzubaidi S, Sakrana A, Gouda M, El Tahlawi R, Sellem A, Melki S, Elajmi W, Hammami H, Okano M, Kato T, Kimura M, Funasako M, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko M, Massardo T, Swett E, Fernandez R, Vera V, Zhindon J, Fernandez R, Swett E, Vera V, Zhindon J, Alay R, Massardo T, Ohshima S, Nishio M, Kojima A, Tamai S, Kobayashi T, Murohara T, Burrell S, Van Rosendael A, Van Den Hoogen I, De Graaf M, Roelofs J, Kroft L, Bax J, Scholte A, Rjabceva I, Krumina G, Kalvelis A, Chanakhchyan F, Vakhromeeva M, Kankiya E, Koppes J, Knol R, Wondergem M, Van Der Ploeg T, Van Der Zant F, Lazarenko SV, Bruin VS, Pan XB, Declerck JM, Van Der Zant FM, Knol RJJ, Juarez-Orozco LE, Alexanderson E, Slart R, Tio R, Dierckx R, Zeebregts C, Boersma H, Hillege H, Martinez-Aguilar M, Jordan-Rios A, Christensen TE, Ahtarovski KA, Bang LE, Holmvang L, Soeholm H, Ghotbi AA, Andersson H, Ihlemann N, Kjaer A, Hasbak P, Gulya M, Lishmanov YB, Zavadovskii K, Lebedev D, Stahle M, Hellberg S, Liljenback H, Virta J, Metsala O, Yla-Herttuala S, Saukko P, Knuuti J, Saraste A, Roivainen A, Thackeray J, Wang Y, Bankstahl J, Wollert K, Bengel F, Saushkina Y, Evtushenko V, Minin S, Efimova I, Evtushenko A, Smishlyaev K, Lishmanov Y, Maslov L, Okuda K, Nakajima K, Kirihara Y, Sugino S, Matsuo S, Taki J, Hashimoto M, Kinuya S, Ahmadian A, Berman J, Govender P, Ruberg F, Miller E, Piriou N, Pallardy A, Valette F, Cahouch Z, Mathieu C, Warin-Fresse K, Gueffet J, Serfaty J, Trochu J, Kraeber-Bodere F, Van Dijk J, Mouden M, Ottervanger J, Van Dalen J, Jager P, Zafrir N, Ofrk H, Vaturi M, Shochat T, Hassid Y, Belzer D, Sagie A, Kornowski R, Kaminek M, Metelkova I, Budikova M, Koranda P, Henzlova L, Sovova E, Kincl V, Drozdova A, Jordan M, Shahid F, Teoh Y, Thamen R, Hara N, Onoguchi M, Hojyo O, Kawaguchi Y, Murai M, Udaka F, Matsuzawa Y, Bulugahapitiya DS, Avison M, Martin J, Liu YH, Wu J, Liu C, Sinusas A, Daou D, Sabbah R, Bouladhour H, Coaguila C, Aguade-Bruix S, Pizzi M, Romero-Farina G, Candell-Riera J, Castell-Conesa J, Patchett N, Sverdlov A, Miller E, Daou D, Sabbah R, Bouladhour H, Coaguila C, Smettei O, Abazid R, Boulaamayl El Fatemi S, Sallam L, Snipelisky D, Park J, Ray J, Shapiro B, Kostkiewicz M, Szot W, Holcman K, Lesniak-Sobelga A, Podolec P, Clerc O, Possner M, Liga R, Vontobel J, Mikulicic F, Graeni C, Benz D, Herzog B, Gaemperli O, Kaufmann P. Poster Session 1: Sunday 3 May 2015, 08:30-18:00 * Room: Poster Area. Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
17
|
Bartczak A, Plaskota K, Trojnarska O, Szczepaniak-Chichel L, Popiel M, Grajek S, Eindhoven JA, Van Den Bosch A, Ruys T, Opic P, Cuypers J, Mc Ghie - Vletter J, Witsenburg M, Boersma H, Roos-Hesselink J, Carro A, Sanz M, Galuppo V, Maldonado G, Santos A, Miranda B, Huguet F, Gonzalez N, Abad C, Evangelista A, Eindhoven JA, Van Den Bosch A, Menting M, Cuypers J, Witsenburg M, Vletter- Mcghie J, Ruys P, Boermsa H, Roos-Hesselink J, Dragulescu A, Mroczek D, Chaturvedi R, Benson L, Friedberg M, Mertens L, Nastase O, Enache R, Popescu B, Botezatu D, Aschie D, State S, Rosca M, Calin A, Beladan C, Ginghina C, Huang F, Zhong L, Tan J, Le T, Tan R, Pietrzak R, Werner B, Scognamiglio G, Karonis T, Gatzoulis M, Babu-Narayan S, Li W, Gonzalez-Gonzalez A, Alonso-Gonzalez R, West C, Senior R, Li W. Moderated Posters session * Congenital heart disease: 12/12/2013, 14:00-18:00 * Location: Moderated Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet209] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Simsek C, Karanasos A, Magro M, Garcia-Garcia H, Onuma Y, Regar E, Boersma H, Serruys P, Van Geuns R. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5488] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Lipton JA, Barendse RJ, Van Domburg RT, Schinkel AFL, Boersma H, Simoons MI, Akkerhuis KM. Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit. Eur Heart J Acute Cardiovasc Care 2013; 2:306-13. [PMID: 24338289 DOI: 10.1177/2048872613489304] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
AIMS Hyperglycemia is associated with increased mortality in cardiac patients. However, the predictive value of admission- and average glucose levels in patients admitted to an intensive cardiac care unit (ICCU) has not been described. METHODS Observational study of patients admitted to the ICCU of a tertiary medical center in whom glucose levels were measured at and during admission. Over a 19-month period, 1713 patients were included. Mean age was 63±14 years, 1228 (72%) were male, 228 (17%) had known diabetes. Median (interquartile) glucose levels at admission were 7.9 (6.5-10.1) mmol/l; median glucose levels during ICCU admission (873 patients with three or more measurements) were 7.3 (6.7-8.3) mmol/l. Cox regression analysis was performed including the variables age, gender, admission diagnosis, length of stay, prior (cardio)vascular disease and diabetes. RESULTS A 1 mmol/l increase in admission glucose level (above 9 mmol/l) was associated with a 10% (95% confidence interval (CI): 7 -13%) increased risk for all-cause mortality. A 1 mmol/l higher average glucose level (above 8 mmol/l) was an additional independent predictor of mortality (HR 1.11, 95% CI: 1.03 - 1.20). At 30 days, 16.8% (97/579) of the patients with an admission glucose level in the highest tertile (>9.8 mmol/L) had died vs 5.2% (59/1134) of those with a lower admission glucose level. CONCLUSION In a high risk ICCU population, both high admission glucose levels as well as high average glucose levels during hospitalization were independently associated with increased mortality, even when accounting for other risk factors and parameters of disease severity.
Collapse
Affiliation(s)
- J A Lipton
- Department of Cardiology, Erasmus Medical Center, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
20
|
Helderman F, Manoch I, Breeuwer M, Kose U, Boersma H, van Sambeek M, Pattynama P, Schouten O, Poldermans D, Wisselink W, van der Steen A, Krams R. Predicting Patient-Specific Expansion of Abdominal Aortic Aneurysms. J Vasc Surg 2010. [DOI: 10.1016/j.jvs.2010.05.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Nieman K, Galema T, Weustink A, Neefjes L, Moelker A, Musters P, de Visser R, Mollet N, Boersma H, de Feijter PJ. Computed tomography versus exercise electrocardiography in patients with stable chest complaints: real-world experiences from a fast-track chest pain clinic. Heart 2009; 95:1669-75. [DOI: 10.1136/hrt.2009.169441] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
22
|
Abstract
BACKGROUND The prognosis of patients with estabLished coronary artery improves if smoking is stopped. Still, about half of patients who suffer a myocardial infarction continue smoking after that event. In order to predict to whom additional support should be offered, various baseline characteristics were compared with smoking status at short-term and long-term follow-up. METHODS Demographics, medical history, presence of coronary risk factors, psychological determinants, and the clinical course were recorded in a group of 530 unselected consecutive patients who had been admitted with a myocardial infarction and were smoking. Patients who were smoking at admission, and who were alive at 4-year follow-up, were studied to relate smoking status and baseline characteristics. RESULTS At 3 months, persistent smokers were younger than quitters, had shorter hospital stays, underwent revascularization procedures less often, smoked more cigarettes per day at baseline, and were more socially isolated. After 4 years, patients who stopped smoking had had a more serious myocardial infarction and had a lower displeasure score than those who continued smoking. Also, quitters received more support from their social environment. CONCLUSIONS Although the majority of the patients try to stop smoking after a myocardial infarction, about half smokes after 4 years. In the future, special support should be offered to smokers who suffer myocardial infarction, especially to those whose psychosocial profiles are less favorable.
Collapse
Affiliation(s)
- T F van Berkel
- Thoraxcenter, University Hospital Rotterdam, The Netherlands.
| | | | | |
Collapse
|
23
|
van der Vlugt MJ, Boersma H, Leenders CM, Pop GA, Veerhoek MJ, Simoons ML, Deckers JW. Prospective study of early discharge after acute myocardial infarction (SHORT). Eur Heart J 2000; 21:992-9. [PMID: 10901511 DOI: 10.1053/euhj.1999.1943] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
AIMS To identify, without additional investigation, a large group of myocardial infarction patients at low risk who would qualify for early discharge. METHODS The decision rule was developed in 647 unselected patients with consecutively admitted myocardial infarction, and validated in 825 others. Daily event-rates were calculated for major (death, ventricular fibrillation, recurrent infarction, heart failure, advanced AV-block) and minor (unstable angina and rhythm-abnormalities) cardiac complications. RESULTS Patients free from major complications until day 7 (44% of all patients) were found to constitute a very low risk group and thus would qualify for discharge at day 7. Of the 39% of patients with an uncomplicated infarction (low risk) in the validation group, 31% were discharged at day 7, while 8% stayed longer because of non-cardiac co-morbidity, for social reasons or logistic problems. No major adverse event occurred within 7 days after hospital discharge and only 1.8% developed complications within 1 month. The median duration of hospital stay for all in-hospital survivors was 7 days compared to 10 days in the control group. CONCLUSION Prospective application of the early discharge decision rule, based upon simple clinical variables and without the need for additional non-invasive and/or invasive tests, resulted in a significant reduction of hospital stay. The decision rule correctly classified patients into high and low risk groups and appeared feasible and safe. Its efficacy was demonstrated by its ability to identify a large group of post infarction survivors at low risk for complications during follow-up.
Collapse
Affiliation(s)
- M J van der Vlugt
- Rotterdam Heartcenter, location Thoraxcenter, University Hospital Rotterdam Dijkzigt, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
24
|
van Berkel TF, Boersma H, Roos-Hesselink JW, Erdman RA, Simoons ML. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J 1999; 20:1773-82. [PMID: 10581135 DOI: 10.1053/euhj.1999.1658] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- T F van Berkel
- Department of Cardiology, Heartcentre, Rotterdam, The Netherlands
| | | | | | | | | |
Collapse
|
25
|
van Berkel TF, Boersma H, De Baquer D, Deckers JW, Wood D. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. Eur Heart J 1999; 20:1630-7. [PMID: 10543926 DOI: 10.1053/euhj.1999.1635] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
AIMS To establish to what extent smoking status and its management is recorded in coronary patients' medical records, and to investigate their motivation to change smoking behaviour. METHODS In EUROASPIRE, a survey on secondary prevention in 21 hospitals in the Czech Republic, Finland, France, Germany, Hungary, Italy, the Netherlands, Slovenia and Spain, data were collected from records of 4863 consecutive patients =<70 years of age, with previous (>6 months) admission for coronary bypass operation, angioplasty, myocardial infarction or ischaemia. Of these, 3569 patients were interviewed 1.6 years following their index hospitalization. RESULTS Of the 82% of patients whose pre-hospitalization smoking behaviour was known, 34% were smokers. Documentation was significantly better in younger patients, in males and patients requiring angioplasty or bypass operation. In only 35% of 1364 smokers was the smoking habit recorded again after discharge from hospital At the time of the interview, 554 of the interviewed patients were still smoking. In over 90% of the smokers, advice to quit smoking was reported at interview. A positive relationship was found between receiving advice and seeking help to stop smoking, between receiving advice to stop smoking and attempting to stop, as well as between seeking help and attempting to stop. CONCLUSION In almost 20% of coronary patients, smoking habits are not documented in medical records, and in only 35% of the smoking patients is smoking status documented at the follow-up. After a cardiac event requiring hospitalization as many as 50% of patients continue their smoking habit and so there is further potential to reduce the risk of recurrent coronary disease. Advice to stop smoking motivates patients to seek help and to attempt to stop smoking. Physicians repeated advice to stop smoking is important and smoking status should always be documented at follow-up.
Collapse
Affiliation(s)
- T F van Berkel
- Department of Cardiology, Heartcentre, Rotterdam, The Netherlands
| | | | | | | | | |
Collapse
|
26
|
Klootwijk P, Lenderink T, Meij S, Boersma H, Melkert R, Umans VA, Stibbe J, Müller EJ, Poortermans KJ, Deckers JW, Simoons ML. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina. Eur Heart J 1999; 20:1101-11. [PMID: 10413640 DOI: 10.1053/euhj.1999.1477] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
AIMS Thrombin plays a key role in the clinical syndrome of unstable angina. We investigated the safety and efficacy of five dose levels of efegatran sulphate, a direct thrombin inhibitor, compared to heparin in patients with unstable angina. METHODS Four hundred and thirty-two patients with unstable angina were enrolled. Five dose levels of efegatran were studied sequentially, ranging from 0.105 mg. kg(-1). h(-1)to 1.2 mg. kg(-1). h(-1)over 48 h. Safety was assessed clinically, with reference to bleeding and by measuring clinical laboratory parameters. Efficacy was assessed by the number of patients experiencing any episode of recurrent ischaemia as measured by computer-assisted continuous ECG ischaemia monitoring. Clinical end-points were: episodes of recurrent angina, myocardial infarction, coronary intervention (PTCA or CABG), and death. RESULTS Efegatran demonstrated dose dependent ex-vivo anticoagulant activity with the highest dose level of 1.2 mg. kg(-1). h(-1)resulting in steady state mean activated partial thromboplastin time values of approximately three times baseline. Thrombin time was also increased. Neither of the efegatran doses studied were able to suppress myocardial ischaemia during continuous ECG ischaemia monitoring to a greater extent than that seen with heparin. There were no statistically significant differences in clinical outcome or major bleeding between the efegatran and heparin groups. Minor bleeding and thrombophlebitis occurred more frequently in the efegatran treated patients. CONCLUSION Administration of efegatran sulphate at levels of at least 0.63 mg. kg(-1). h(-1)provided an anti-thrombotic effect which is at least comparable to an activated partial thromboplastin time adjusted heparin infusion. There was no excess of major bleeding. The level of thrombin inhibition by efegatran, as measured by activated partial thromboplastin time, appeared to be more stable than with heparin. Thus, like other thrombin inhibitors, efegatran sulphate is easier to administer than heparin. However, no clinical benefits of efegatran over heparin were apparent.
Collapse
Affiliation(s)
- P Klootwijk
- Department of Cardiology, Rotterdam Heart Centre, Division Thoraxcentre, The Netherlands
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Boersma H. [How does one handle tooth crowding after extraction of deciduous teeth?]. Ned Tijdschr Tandheelkd 1999; 106:234. [PMID: 12141228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
|
28
|
van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997; 68:95-102. [PMID: 9207591 DOI: 10.1016/s0015-0282(97)81482-3] [Citation(s) in RCA: 265] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE To verify whether a population-based hypothesis (age at menarche and age at natural menopause have an inverse relationship) also applies at the level of the individual and to investigate what other factors predict age at natural menopause. DESIGN Prospective cohort study (the Doorlopend Onderzoek Morbiditeit/Mortaliteit [DOM] project). SETTING Prevention Breast Cancer Screening Centre, Utrecht, The Netherlands. PATIENT(S) A cohort of 3,756 Dutch women, born between 1911 and 1925, participating in a population-based breast cancer screening program, who experienced a natural menopause. Three samples of women were studied: a sample who did not use oral contraceptives (OCs) (n = 3,347), a sample of OC users (n = 409), and a combined sample of OC users and nonusers (n = 3,756). MAIN OUTCOME MEASURE(S) Age at menopause and menarche, fertility patterns, OC use, height, weight, smoking, and demographic variables. RESULT(S) No relation was found between age at menarche and age at natural menopause. The total percentage of variance in age at natural menopause explained by multiple regression including all factors was minimal, ranging from 1.3% to 9.7% in OC users. Linear regression analysis indicated a slight secular trend in age at menopause. CONCLUSION(S) Frisch's hypothesis could not be corroborated at the individual level. These results suggest that age at menarche and menopause should be treated as independent risk factors for breast cancer. Modification of age at menopause by lifestyle factors (except possibly for OC use) appears minimal.
Collapse
|
29
|
van Blankenstein JH, Slager CJ, Soei LK, Boersma H, Stijnen T, Schuurbiers JC, Krams R, Lachmann B, Verdouw PD. Cardiac depression after experimental air embolism in pigs: role of addition of a surface-active agent. Cardiovasc Res 1997; 34:473-82. [PMID: 9231030 DOI: 10.1016/s0008-6363(97)00063-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
OBJECTIVE Air bubbles entering the coronary artery may have harmful effects on cardiac function. From the physical point of view it is the relatively high surface tension of the blood-air interface which causes bubbles to trap in small vessels. The aim of the present study was to reduce depression of myocardial function from air embolism by lowering the surface tension of air bubbles. METHODS The effect of using antifoam as a surface-tension-reducing agent on air bubble entrapment and cardiac function was investigated in 6 anesthetized pigs (27 +/- 1 kg) and analyzed using a two-compartment diffusion model. Air bubbles with a diameter of 150 microns were selectively injected into the left anterior descending coronary artery (LADCA) in a carrying fluid in the presence or absence of antifoam. Myocardial systolic segment shortening in the LADCA region (SS-LADCA) was measured by sonomicrometry. Presence of emboli was detected by measuring the amount of reverberation of ultrasound scattered by trapped air bubbles. RESULTS SS-LADCA transiently decreased after injections of air bubbles in both the absence and presence of antifoam. However, in the presence of antifoam the regional depression recovered to normal sooner, the average depth of the depression was reduced, and bubbles from the embolized area cleared faster. These observations can be explained by a model derived from Laplace's law.
Collapse
|
30
|
van Suylen R, van Bekkum E, Boersma H, de Kok L, Balk A, Bos E, Bosman F. Collagen content and distribution in the normal and transplanted human heart: A postmortem quantitative light microscopic analysis. Cardiovasc Pathol 1996; 5:61-8. [DOI: 10.1016/1054-8807(95)00087-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/1995] [Accepted: 07/25/1995] [Indexed: 11/26/2022] Open
|
31
|
Boersma H, van der Vlugt MJ, Arnold AE, Deckers JW, Simoons ML. Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. Eur Heart J 1996; 17:64-75. [PMID: 8682132 DOI: 10.1093/oxfordjournals.eurheartj.a014693] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
Currently several modes of reperfusion therapy for acute myocardial infarction are available. Streptokinase, accelerated alteplase and direct angioplasty are the most frequently used. These options are increasingly effective, but are also increasingly complex and costly. Since, unfortunately, physicians are often restricted by budget limitations, choices must be made in clinical practice to provide optimal therapy to individual patients. In order to guide such decision making, we developed a model to predict the expected benefit of therapy in terms of gain in life expectancy. Patients' life expectancy will decrease after infarction. Part of this loss can be prevented by early reperfusion therapy. The clinical benefit of therapy ranges from negligible gain in patients with small infarcts treated relatively late to an expected gain of more than 2 years in patients with extensive infarction treated within 3 h of onset of symptoms. The expected benefits are presented in a set of tables and depend on age, previous infarction, estimated infarct size, treatment delay and intracranial bleeding risk. With the help of these table, resources will be allocated in such a manner that patients who will benefit the most will receive the most effective therapy. Patients with similar expected treatment benefit will be offered the same mode of therapy. Future life years were discounted at 5% per year. The arbitrary thresholds currently applied for decision making at the Thoraxcenter are: no reperfusion therapy when the estimated gain in discounted life expectancy was < 1 month, streptokinase for 1-4 months and accelerated alteplase for a gain > or = 5 months. Direct angioplasty is recommended in patients with an estimated gain > or = 12 months, and in patients with an increased risk of intracranial bleeding. In this way, approximately 80% of our patients will be treated with thrombolytics (40% streptokinase and 40% accelerated alteplase), while in 10% direct angioplasty will be initiated. Patients with small infarcts presenting late will not receive reperfusion therapy. These threshold values have been chosen arbitrarily, and different thresholds may be selected in other centres. However, the developed model would guarantee that treatment decisions are made in a consistent manner, to provide optimal therapy for patients with evolving myocardial infarction, in spite of limited resources.
Collapse
Affiliation(s)
- H Boersma
- Thoraxcenter, Erasmus University, The Netherlands
| | | | | | | | | |
Collapse
|
32
|
van Berkel TF, Erdman RA, Breeman A, Boersma H, van den Brand MJ. [Quality of life following coronary surgery and balloon angioplasty; more chest pain and social inhibition following angioplasty]. Ned Tijdschr Geneeskd 1995; 139:1733-7. [PMID: 7566240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
OBJECTIVE To determine the differences in quality of life between patients who had a coronary artery bypass graft (CABG) and patients who had a percutaneous transluminal coronary angioplasty (PTCA). DESIGN Comparative and prospective study. SETTING Rotterdam, the Netherlands. METHOD 91 patients with multi-vessel coronary disease who had been randomised to CABG (n = 37) or PTCA (n = 54), as participants in the CABRI study (Coronary angioplasty or bypass revascularisation investigation) completed several psychological questionnaires. Besides, the severity of angina pectoris after the procedure was estimated using the Canadian Cardiovascular Society score. In a subpopulation of 36 patients (CABG:14; PTCA:22) the quality of life just before the intervention was measured, also using psychological questionnaires. RESULTS A significant difference in angina pectoris was found between the two groups. The PTCA group experienced more chest pain (p < 0.01), at an average of 2.6 years after the intervention. The quality of life aspects did not differ between the two groups, except for 'social inhibition' (p < 0.05): the PTCA group experienced more problems and had less energy (p < 0.01). No significant differences between the PTCA and CABG groups were found regarding to the change in quality of life caused by the intervention. CONCLUSION The persistent angina pectoris and social inhibition among patients who have had a PTCA need further study.
Collapse
Affiliation(s)
- T F van Berkel
- Afd. Cardiologie, Academisch Ziekenhuis Rotterdam-Dijkzigt
| | | | | | | | | |
Collapse
|
33
|
Boersma H. [Tertiary crowding in the lower front teeth. Two observations]. Ned Tijdschr Tandheelkd 1995; 102:90-1. [PMID: 11837076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
Tertiary crowding, especially in the lower dentition, is shortly discussed. Two cases are illustrated that show the uncertainty regarding the often stated influence of the third molars in this respect.
Collapse
Affiliation(s)
- H Boersma
- Vakgroep Orthodontie, Faculteit der Medische Wetenschappen, Katholieke Universiteit, Nijmegen
| |
Collapse
|
34
|
el-Said ES, Roelandt JR, Fioretti PM, McNeill AJ, Forster T, Boersma H, Linker DT. Abnormal left ventricular early diastolic filling during dobutamine stress Doppler echocardiography is a sensitive indicator of significant coronary artery disease. J Am Coll Cardiol 1994; 24:1618-24. [PMID: 7963106 DOI: 10.1016/0735-1097(94)90165-1] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
OBJECTIVES This study was designed to assess changes in Doppler indexes of left ventricular ejection and filling in response to high dose (40 micrograms/kg body weight per min) dobutamine stress and their utility in detection of coronary artery disease compared with that of new wall motion abnormalities. METHODS Ten patients with a low likelihood of coronary artery disease served as a control group, and 23 patients with documented single-vessel coronary artery disease underwent baseline and peak dobutamine echocardiographic and Doppler studies. RESULTS In both groups dobutamine induced similar increases in heart rate and systolic blood pressure. During the test, 14 patients had new wall motion abnormalities, 13 had angina, and 7 had electrocardiographic ST segment changes. No markers of ischemia occurred in the control subjects. Dobutamine induced qualitatively similar changes from baseline to peak dobutamine stress in control subjects and patients in peak aortic velocity (46% vs. 42%, p = NS), average aortic acceleration (61% vs. 43%, p = 0.03) and systolic time-velocity integral (7% vs. 2%, p = NS). Dobutamine caused marked increases in control subjects and decreases in patients in peak early filling velocity (E) (33% vs. -22%, p < 0.0001) and average E acceleration (76% vs. -28%, p < 0.0001). The response of Doppler early filling indexes to dobutamine stress was abnormal in all patients. There was no overlap in the percent change from baseline to peak dobutamine stress between control subjects and patients for E and E acceleration. CONCLUSIONS During dobutamine stress testing, an abnormal response of Doppler indexes of left ventricular early filling is a more sensitive marker of significant single-vessel coronary disease than are new wall motion abnormalities, and it is far superior to the response of Doppler ejection variables as a predictor of coronary artery disease.
Collapse
Affiliation(s)
- E S el-Said
- Thoraxcenter, University Hospital Rotterdam-Dijkzigt, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
35
|
van Blankenstein JH, Slager CJ, Soei LK, Boersma H, Verdouw PD. Effect of arterial blood pressure and ventilation gases on cardiac depression induced by coronary air embolism. J Appl Physiol (1985) 1994; 77:1896-902. [PMID: 7836215 DOI: 10.1152/jappl.1994.77.4.1896] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
In this study the time course of cardiac depression after selective intracoronary injection of air bubbles was investigated in six anesthetized pigs (30 +/- 2 kg) with different mixtures of ventilation gases and different mean arterial blood pressures (MAP). Air bubbles of 150 microns diam were injected into the left anterior descending coronary artery (LADCA) in a volume of 2 microliters/kg body wt. In each animal an injection of air bubbles was applied during ventilation with N2-O2 and a MAP of 77 +/- 3 mmHg (N2-O2/low pressure) or 111 +/- 3 mmHg (N2-O2/high pressure) and during ventilation with pure O2 and a MAP of 77 +/- 3 mmHg (O2/low pressure) or 110 +/- 3 mmHg (O2/high pressure). Systemic hemodynamic variables such as left ventricular pressure, its peak first derivatives, and MAP changed < 10% after injection of air bubbles. During N2-O2/low pressure, systolic segment length shortening in the LADCA region (SS-LADCA) decreased from baseline and did not return to baseline within the 10 min after injection of air bubbles. During N2-O2/high pressure and O2/low pressure, SS-LADCA was decreased between 60 and 120 s, whereas for O2/high pressure this period was from 60 to 90 s. By calculating the time integral of the deviation from baseline of SS-LADCA, it could be demonstrated that the depression of regional myocardial function was less severe during O2/high pressure and O2/low pressure than during N2-O2/low pressure. We conclude that, when coronary air embolism occurs during hypertension and during ventilation with pure O2 instead of a normal N2-O2 mixture, the resulting depression of regional myocardial function is reduced.
Collapse
|
36
|
Abstract
In a consecutive series of 149 patients with congenital ventricular septal defect (VSD), temporary tricuspid valve detachment was applied in 39 (detached group) to facilitate the transatrial approach for closure of the defect. Baseline characteristics showed that, preoperatively, the detached group were younger (1.3 +/- 2.3 vs. 3.5 +/- 4.1 years, P = 0.002), shorter (0.67 +/- 0.20 vs 0.87 +/- 0.34 m, P = 0.001), lighter (6.9 +/- 5.4 vs 13.5 +/- 12.0 kg, P < 0.002), and had a higher mean right atrial pressure (6 +/- 2 vs 4 +/- 3 mm Hg, P < 0.003), mean end-diastolic right ventricular pressure (10 +/- 3 vs 8 +/- 3 mm Hg, P < 0.01) and mean pulmonary vascular resistance (267 +/- 202 vs 170 +/- 131 dyn s cm-5, P < 0.02) on cardiac catheterization. At surgery the aortic cross-clamp time was longer (48 +/- 17 vs 39 +/- 15 min, P = 0.003). Seven patients died (2 detached, 5 not-detached), from causes not related to either tricuspid detachment or VSD closure. Follow-up was complete with a mean duration of 2.0 years (range 0.1-5.5). All 142 survivors were investigated by echocardiography, which showed normal tricuspid valve function in all but 29 patients who had trivial regurgitation (6 detached, 23 not-detached). There was no tricuspid stenosis. In 30 patients (8 detached, 22 not-detached) a trivial residual VSD could be detected. One reoperation (not-detached) was performed 12.5 months after the initial surgery for recurrent VSD.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- G Bol-Raap
- Department of Cardiothoracic Surgery, University Hospital Dijkzigt, Rotterdam, The Netherlands
| | | | | | | | | | | |
Collapse
|
37
|
Meeter K, Honkoop P, Verhage AH, Boersma H, Fioretti P, Deckers JW. [The treatment of myocardial infarction during the hospital stage and shortly thereafter: now and 10 years ago]. Ned Tijdschr Geneeskd 1993; 137:1922-6. [PMID: 8413694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
OBJECTIVE Comparison between the early and the late eighties of the application of thrombolysis and revascularisation in the acute phase of a myocardial infarction. LOCATION University Hospital, Rotterdam. DESIGN Prospective with historical comparison. METHODS All patients admitted between May 1987 and May 1990 with a myocardial infarction and aged up to 71 years were included (n = 430). Numbers of procedures and survival during the following year were compared with data of patients admitted from 1981 to the end of 1983 (n = 706). RESULTS In 1981-1983 thrombolytics were administered to 9% of the patients, in 1987-1990 to 40%. Revascularisation procedures during the next year were performed in 17% and 50% of the patients respectively. Hospital mortality decreased from 14% to 10% (p < 0.05), one-year survival increased from 75% to 83% (p < 0.05). For patients from 1987-1990 one-year survival was higher after thrombolysis treatment: 90% versus 78% without (p < 0.01), and after revascularisation: 94% versus 87% without (p < 0.01). CONCLUSION Compared with 1981-1983 the treatment is at present more directed towards reperfusion and revascularisation of the ischaemic myocardium, resulting in invasive treatment in 50% of the patients now as opposed to 25% in the early eighties. The survival rate during the first year has improved.
Collapse
Affiliation(s)
- K Meeter
- Academisch Ziekenhuis Rotterdam-Dijkzigt, Thoraxcentrum
| | | | | | | | | | | |
Collapse
|
38
|
Boersma H. [Treatments of Class II-patients with headgear]. Ned Tijdschr Tandheelkd 1990; 97:406-13. [PMID: 2130262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Treatments with headgears are illustrated. Some theoretical aspects are discussed. A correct period of wear, as well as a reserve in magnitude of forces is strongly advocated.
Collapse
|
39
|
Boersma H, van der Linden FP. [The (post)graduate training of orthodontists]. Ned Tijdschr Tandheelkd 1990; 97:247-9. [PMID: 2215813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
40
|
Boersma H. [Spontaneous corrections and orthodontic treatment]. Ned Tijdschr Tandheelkd 1990; 97:10-4. [PMID: 2366919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Spontaneous corrections in orthodontic anomalies can sometimes be expected, when all hindrances are eliminated, and the relevant teeth are given every freedom. Although there seems to be no exact explanation for the corrections some speculations are presented. Advantages and disadvantages are discussed.
Collapse
|
41
|
Prahl-Andersen B, Boersma H. [Differences between the orthodontic evaluation of dentitions and profiles are probably existing between lay persons and professional people]. Ned Tijdschr Tandheelkd 1979; 86:292-5. [PMID: 298612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
42
|
Prahl-Andersen B, Boersma H, van der Linden FP, Moore AW. Perceptions of dentofacial morphology by laypersons, general dentists, and orthodontists. J Am Dent Assoc 1979; 98:209-12. [PMID: 284066 DOI: 10.14219/jada.archive.1979.0456] [Citation(s) in RCA: 98] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Line drawings of facial profiles and color photographs of dentitions were evaluated subjectively by 1,150 parents, 72 general practictioners of dentistry, and 54 orthodontists with regard to the normality and abnormality in dentofacial morphology and the need for orthodontic treatment. A significant difference was found between the evaluations of the parents and the professional groups in ten of the 11 facial profiles and in seven of the 11 photographs of dentitions. In general, the parents considered more of the examples acceptable and not requiring orthodontic treatment than did the professional groups. The dentists and orthodontists deviated significantly in their ratings onjy in their judgement of "ugly duckling" example (picture 22, higher abnormal rating by the dentists) and the profile example 10 (higher abnormal rating by orthodontists). number of orthondontists may have associated the conditions in picture 10 with a Class II, Division 2 malocclusion and, as such, scored it abnormal.
Collapse
|
43
|
Prahl-Andersen B, Boersma H, Vissers A. [Parental perception of the need for orthodontic treatment for children]. Ned Tijdschr Tandheelkd 1978; 85:193-7. [PMID: 287881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
44
|
Boersma H. [Comparison of reproducibility of measurements directly on headplates and on tracings]. Ned Tijdschr Tandheelkd 1974; 81:388-90. [PMID: 4535129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
45
|
Boersma H, van der Linden FP. [A new approach to gather information about dental models using the Optocom]. Ned Tijdschr Tandheelkd 1974; 81:60-5. [PMID: 4530172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
46
|
Abstract
Measurements on standardized lateral radiographs of monkey heads and subsequently of the dried skulls did not show statistically significant differences. The error of the method in the heads was on the average six times greater for the linear dimensions and four times greater for the angular dimensions than those in the skulls.
Collapse
|
47
|
|
48
|
Boersma H. [Orthodontic treatment in general practice]. Ned Tijdschr Tandheelkd 1971; 78:304-7. [PMID: 5285578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
49
|
Boersma H. The set-up (I). Placement of teeth on a model as an aid in prediction of therapy results. Quintessence Int (Berl) 1970; 1:45-8. [PMID: 5274821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
50
|
Boersma H. [The "Set-up". 2. Positioning of the teeth of a model as an aid in predicting the results of treatment]. Quintessenz 1970; 21:63-8. [PMID: 5275299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|